Toll-like Receptor 5 Agonism Protects Mice from Radiation Pneumonitis and Pulmonary Fibrosis |
Wang, Zhi-Dong
(Department of Radiation Toxicology and Oncology, Beijing Institute of Radiation Medicine)
Qiao, Yu-Lei (College of Life Science, Hebei United University) Tian, Xi-Feng (College of Life Science, Hebei United University) Zhang, Xue-Qing (Department of Radiation Toxicology and Oncology, Beijing Institute of Radiation Medicine) Zhou, Shi-Xiang (Department of Radiation Toxicology and Oncology, Beijing Institute of Radiation Medicine) Liu, Hai-Xiang (Department of Radiation Toxicology and Oncology, Beijing Institute of Radiation Medicine) Chen, Ying (Department of Radiation Toxicology and Oncology, Beijing Institute of Radiation Medicine) |
1 | Atkinson K, Vos B, Kang-Er Z, et al (1995).Effect of in vivo administration of IL-3 and IL-6, alone and in combination with G-CSF, GM-CSF or IL-1, on haematopoiesis, graftversus- host disease and survival after murine haematopoietic stem cell transplantation. Cytokines Mol Ther, 1, 47-55. |
2 | Brickey WJ, Neuringer IP, Walton W, et al (2012).MyD88 provides a protective role in long-term radiation-induced lung injury. Int J Radiat Biol, 88, 335-47. DOI |
3 | Burdelya LG, Gleiberman AS, Toshkov I, et al (2012). Tolllike receptor 5 agonist protects mice from dermatitis and oral mucositis caused by local radiation: implications for head-and-neck cancer radiotherapy. Int J Radiat Oncol Biol Phys, 83, 228-34. DOI |
4 | Burdelya LG, Krivokrysenko VI, Tallant TC, et al (2008). An agonist of toll-like receptor 5 has radioprotective activity in mouse and primate models. Science, 320, 226-30. DOI |
5 | Dale DC (2002). Colony-stimulating factors for the management of neutropenia in cancer patients. Drugs, 62, S1-15. |
6 | Delanian S, Baillet F, Huart J, et al (1994). Successful treatment of radiation-induced fibrosis using liposomal Cu/Zn superoxide dismutase (clinical trial). Radiother Oncol, 32, 12-20. DOI |
7 | Epperly MW, Sikora CA, DeFilippi SJ, et al (2002).Manganese superoxide dismutase (SOD2) inhibits radiation-induced apoptosis by stabilization of the mitochondrial membrane. Radiat Res, 157, 568-77. DOI ScienceOn |
8 | Krivokrysenko V, Shakhov A, Singh V, et al (2012). Identification of G-CSF and IL-6 as Candidate Biomarkers of CBLB502 Efficacy as a Medical Radiation Countermeasure. J Pharmacol Exp Ther, 343, 497-508. DOI |
9 | Kuwano K, Hagimoto N, Kawasaki M, et al (1999). Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis. J ClinInvest, 104, 13-9 |
10 | Mehta V (2005). Radiation pneumonitis and pulmonary fibrosis in non-small-cell lung cancer: pulmonary function, prediction, and prevention. Int J Radiat Oncol Biol Phys, 63, 5-24. DOI ScienceOn |
11 | Tallant T, Deb A, Kar N, et al (2004). Flagellin acting via TLR5 is the major activator of key signaling pathways leading to NF-kappa B and proinflammatory gene program activation in intestinal epithelial cells. BMCMicrobiol, 4, 33. |
12 | Vijay-Kumar M, Aitken JD, Sanders CJ, et al (2008).Flagellin treatment protects against chemicals, bacteria,viruses, and radiation. J Immunol, 180, 8280-5. DOI |
13 | Wynn TA (2007). Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J Clin Invest, 117, 524-9. DOI |
14 | Zhou SX, Li FS, Qiao YL, et al (2012). Toll-like receptor 5 agonist inhibition of growth of A549 lung cancer cells in vivo in a Myd88 dependent manner. Asian Pac J Cancer Prev, 13, 2807-12. DOI |